insights_auto
Why is SABS down 10,31%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,87 $
arrow_downward
-10,31%(-0,33) 1D
19 қар., 15:48:08 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,20 $
High
3,21 $
Low
2,54 $
Mkt. cap
258,55 млн
Avg. vol.
689,33 м.
Volume
1,31 млн
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
3,20 $
High
3,21 $
Low
2,54 $
Mkt. cap
258,55 млн
Avg. vol.
689,33 м.
Volume
1,31 млн
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
Investing.com
·
2 күн бұрын
SAB Biotherapeutics at UBS conference: late-stage diabetes bet
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Флорида, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitesab.bio